Nova Eye Medical ( (AU:EYE) ) just unveiled an announcement.
Nova Eye Medical announced its half-year financial results for the period ending December 31, 2024. The company reported a 27% increase in revenues from ordinary activities, reaching $12,925,000. Despite the revenue growth, the company experienced a net loss of $5,394,000, which is a 4% decrease compared to the previous period. The earnings per share stood at negative 2.35 cents, and no interim dividend was declared for this period.
More about Nova Eye Medical
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $20.04M
See more insights into EYE stock on TipRanks’ Stock Analysis page.